Literature DB >> 19615630

Cost trajectories at the end of life: the Canadian experience.

Konrad Fassbender1, Robin L Fainsinger, Mary Carson, Barry A Finegan.   

Abstract

A significant proportion of health care resources are consumed at end of life. As a result, decision and policy makers seek cost savings to enhance program planning. Most literature, however, combines the cost of all dying patients and, subsequently, fails to recognize the variation between trajectories of functional decline and utilization of health care services. In this article, we classified dying Albertans by categories of functional decline and assessed their utilization and costs. We used data from two years of health care utilization and costs for three annual cohorts of permanent residents of Alberta, Canada (April 1999 to March 2002). Literature, expert opinion, and cluster analysis were used to categorize the deceased according to sudden death, terminal illness, organ failure, frailty, and other causes of death. Expenditures were decomposed into constituent quantities and prices. We found that nearly 18,000 die per year in Alberta: sudden death (7.1%), terminal illness (29.8%), organ failure (30.5%), frailty (30.2%), and other causes (2.3%). Inpatient care remains the primary cost driver for all trajectories. Significant and predictable health care services are required by noncancer patients. Trajectories of costs are significantly different for the four categories of dying Albertans. Trajectories of dying are a useful classification for analyzing health care use and costs.

Entities:  

Mesh:

Year:  2009        PMID: 19615630     DOI: 10.1016/j.jpainsymman.2009.04.007

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  49 in total

1.  Successful aging as a continuum of functional independence: lessons from physical disability models of aging.

Authors:  Kristin A Lowry; Abbe N Vallejo; Stephanie A Studenski
Journal:  Aging Dis       Date:  2011-08-15       Impact factor: 6.745

2.  Vascular depression: an early warning sign of frailty.

Authors:  Daniel Paulson; Peter A Lichtenberg
Journal:  Aging Ment Health       Date:  2012-06-25       Impact factor: 3.658

3.  The Myth Regarding the High Cost of End-of-Life Care.

Authors:  Melissa D Aldridge; Amy S Kelley
Journal:  Am J Public Health       Date:  2015-10-15       Impact factor: 9.308

Review 4.  Frailty Clinical Phenotype: A Physical and Cognitive Point of View.

Authors:  Mylene Aubertin-Leheudre; Adam J Woods; Stephen Anton; Ronald Cohen; Marco Pahor
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2015-10-20

5.  Depression and frailty: concurrent risks for adverse health outcomes.

Authors:  Matthew C Lohman; Briana Mezuk; Levent Dumenci
Journal:  Aging Ment Health       Date:  2015-10-21       Impact factor: 3.658

Review 6.  The use of hospital-based services by heart failure patients in the last year of life: a discussion paper.

Authors:  Gursharan K Singh; Patricia M Davidson; Peter S Macdonald; Phillip J Newton
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

7.  Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study.

Authors:  Sean M Bagshaw; H Thomas Stelfox; Robert C McDermid; Darryl B Rolfson; Ross T Tsuyuki; Nadia Baig; Barbara Artiuch; Quazi Ibrahim; Daniel E Stollery; Ella Rokosh; Sumit R Majumdar
Journal:  CMAJ       Date:  2013-11-25       Impact factor: 8.262

8.  Cumulative Inequality at the End of Life?: Racial Disparities in Impairment in the Time Before Death.

Authors:  Miles G Taylor; Stella N Min; Keshia M Reid
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-06-02       Impact factor: 4.077

9.  Low socioeconomic status is associated with more aggressive end-of-life care for working-age terminal cancer patients.

Authors:  Chun-Ming Chang; Chin-Chia Wu; Wen-Yao Yin; Shiun-Yang Juang; Chia-Hui Yu; Ching-Chih Lee
Journal:  Oncologist       Date:  2014-10-23

Review 10.  Palliative care reduces morbidity and mortality in cancer.

Authors:  Gabrielle B Rocque; James F Cleary
Journal:  Nat Rev Clin Oncol       Date:  2012-12-18       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.